glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://cdn.sanity.io/images/0vv8moc6/pharmexec/a423b703669ea858bb2ce82a2711e9eda7287296-1280x720.png/drug%20discovery%20partnership%2016x9.png?w=1280&max-h=720&fit=crop&auto=format)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://imgproxy.divecdn.com/Uen3WaSRQrS4Q4Ruldy39jm7wp7yZKOh-bFeEbuMcFE/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMzMjU3LmpwZw==.webp)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://www.statnews.com/wp-content/uploads/2019/08/GettyImages-463683050-645x645.jpg)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://d3t5t78xsxj5vn.cloudfront.net/Pictures/380x253/1/8/4/20184_cdcwithdomina500_918232.jpg)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche Announces Positive Topline Results](https://rejuven8peptides.com/wp-content/uploads/2026/02/rejuven8-peptides-glp1-5mg.png)




















